Tumor Therapeutic Regimens and Comprehensive Evaluation: A Comprehensive Evaluation of Malignant Tumor Treatments for Clinicians

Li, Qiu, Zhang, Xiao-Shi

  • 出版商: Springer
  • 出版日期: 2024-08-12
  • 售價: $4,030
  • 貴賓價: 9.5$3,829
  • 語言: 英文
  • 頁數: 469
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 981991423X
  • ISBN-13: 9789819914234
  • 海外代購書籍(需單獨結帳)

相關主題

商品描述

This book starts from the clinical reality, take practicality as the purpose, closely integrate clinical work, including important clinical therapeutic regimens for various cancer, and describes the new developments in treatment of common malignant tumors. At the same time, in combination with improved version of the ASCO value framework, systematic and standardized comparisons and in-depth evaluations of therapeutic regimens were made to promote the standardization of medical treatment decisions for malignant tumors.

Compared with the traditional evaluation method of malignant tumor therapeutic regimens, the evaluation method of this book has outstanding advantages. First, the evaluation indicators are comprehensive and diverse. The evaluation includes multiple indicators such as clinical benefits, adverse reactions, additional benefits, and costs, and includes more effective evaluation indicators to comprehensively evaluate the treatment plan. Second, the evaluation indicatorsare converted into numerical values, and different indicators are effectively quantified to make the result evaluation easier and more objective.

This book systematically and comprehensively reflects the highest level of diagnosis and treatment of common oncology from a new perspective. It has great clinical guidance value and will be a valuable reference book for clinicians, medical students, graduate students and related researchers.

商品描述(中文翻譯)

本書從臨床現實出發,以實用性為目的,緊密結合臨床工作,包括各種癌症的重要臨床治療方案,並描述了常見惡性腫瘤治療的新進展。同時,結合改進版的ASCO價值框架,對治療方案進行了系統化和標準化的比較與深入評估,以促進惡性腫瘤醫療決策的標準化。

與傳統的惡性腫瘤治療方案評估方法相比,本書的評估方法具有顯著優勢。首先,評估指標全面且多樣化。評估包括臨床效益、不良反應、額外效益和成本等多個指標,並納入更有效的評估指標,以全面評估治療計劃。其次,評估指標轉換為數值,並有效量化不同指標,使結果評估更容易且更客觀。

本書從新視角系統而全面地反映了常見腫瘤學的最高診療水平,具有很大的臨床指導價值,將成為臨床醫生、醫學生、研究生及相關研究人員的重要參考書籍。

作者簡介

Editor Qiu Li is a professor at the Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.

Editor Xiao-Shi Zhang is a professor at the Biotherapy Center, Sun Yat-sen University Cancer Center, Guangzhou, China.

作者簡介(中文翻譯)

編輯邱莉是中國四川大學華西醫院癌症中心的教授。

編輯張小石是中國廣州中山大學癌症中心生物療法中心的教授。